Understanding how immune cells in the lungs protect against infections
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
This research explores how special immune cells called macrophages in your lungs help fight off infections like viruses and fungi, aiming to improve our understanding of lung protection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11123405 on NIH RePORTER |
What this research studies
Lung infections are a major health concern worldwide, and our bodies rely on immune cells called macrophages to defend against them. These macrophages are like the front-line defenders in your lungs, crucial for fighting off various invaders such as parasites, fungi, and viruses, including those related to COVID-19. We want to learn more about how these important cells work and how different types of macrophages in the lung contribute to immunity. By understanding these mechanisms, we hope to find better ways to protect lung health and fight infections.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to benefit anyone susceptible to or suffering from lung infections, including those impacted by viruses like COVID-19.
Not a fit: Patients not experiencing or at risk for lung infections would not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing and treating severe lung infections by enhancing the body's natural immune responses.
How similar studies have performed: While the critical role of lung macrophages is known, this research explores new details about different macrophage types and their specific functions, building on emerging scientific understanding.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Rivera, Amariliz — Rutgers Biomedical and Health Sciences
- Study coordinator: Rivera, Amariliz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.